Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy
- 24 November 2020
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 70 (6) , 1605-1617
Abstract
Tumor immunogenicity is driven by various genomic and transcriptomic factors but the association with the overall status of methylation aberrancy is not well established. We analyzed The Cancer Genome Atlas pan-cancer database to investigate whether the overall methylation aberrancy links to the immune evasion of tumor. We created the definitions of hypermethylation burden, hypomethylation burden and methylation burden to establish the values that represent the degree of methylation aberrancy from human methylation 450 K array data. Both hypermethylation burden and hypomethylation burden significantly correlated with global methylation level as well as methylation subtypes defined in previous literatures. Then we evaluated whether methylation burden correlates with tumor immunogenicity and found that methylation burden showed a significant negative correlation with cytolytic activity score, which represent cytotoxic T cell activity, in pan-cancer (Spearman rho = − 0.37, p < 0.001) and 30 of 33 individual cancer types. Furthermore, this correlation was independent of mutation burden and chromosomal instability in multivariate regression analysis. We validated the findings in the external cohorts and outcomes of patients who were treated with immune checkpoint inhibitors, which showed that high methylation burden group had significantly poor progression-free survival (Hazard ratio 1.74, p = 0.038). Overall, the degree of methylation aberrancy negatively correlated with tumor immunogenicity. These findings emphasize the importance of methylation aberrancy for tumors to evade immune surveillance and warrant further development of methylation biomarker.Keywords
Funding Information
- Korea Health Industry Development Institute (HI17C0048)
This publication has 53 references indexed in Scilit:
- Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic ProfilingScience Translational Medicine, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- Intragenic DNA methylation: implications of this epigenetic mechanism for cancer researchBritish Journal of Cancer, 2011
- Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicineGenome Medicine, 2011
- Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysisBMC Bioinformatics, 2010
- Dna Hypomethylation In Cancer CellsEpigenomics, 2009
- Cancer DNA Methylation: Molecular Mechanisms and Clinical ImplicationsClinical Cancer Research, 2009
- GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductorBioinformatics, 2007